Synthetic Biology Technology In Healthcare Market, Global Outlook and Forecast 2025-2031

The global Synthetic Biology Technology In Healthcare market was valued at 4566 million in 2024 and is projected to reach US$ 10430 million by 2031, at a CAGR of 12.7% during the forecast period.

Synthetic biology technology in healthcare refers to the use of principles and methods of synthetic biology to design and construct new biological components, systems, or machines to improve the overall effectiveness of healthcare and disease treatment. Synthetic biology techniques in healthcare typically include gene editing technology, metabolic engineering, cell factory design, synthetic genomics, and other fields, mainly applied in drug development, vaccine design and production, gene therapy, cell therapy, microecological therapy, and other areas.

The synthetic biology technology market in healthcare has maintained a growth trend in recent years. The application of synthetic biology technology in the development of biosimilars and personalized drugs is particularly prominent. With the maturity of gene editing technology, synthetic biology technology has rapidly developed in gene therapy and cell therapy, becoming an important driving force in the field of healthcare. In addition, biosensors and diagnostic tools based on synthetic biology technology are driving the development of precision medicine. The main market participants include multinational pharmaceutical companies such as Pfizer, Merck, and Johnson&Johnson, which have deep technological accumulation and market influence in the biopharmaceutical field, biotechnology companies such as Ginkgo Bioworks and Amyris, which focus on using synthetic biology technology to produce high value-added products, and Chinese companies such as BGI Genomics and BeiGene achieving results in gene editing and drug development. In the future, breakthroughs in technologies such as gene editing and high-throughput screening will further promote the application of synthetic biology in healthcare. Governments of various countries will continue to increase their policy support and funding investment in synthetic biology technology, providing strong guarantees for the development of the industry. The application of synthetic biology technology in healthcare is reshaping the industry landscape, and its efficient, precise, and sustainable features will provide more new solutions for drug development, disease treatment, and diagnosis.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Synthetic Biology Technology In Healthcare companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Synthetic Biology Technology In Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Synthetic Biology Technology In Healthcare. This report contains market size and forecasts of Synthetic Biology Technology In Healthcare in global, including the following market information:
Global Synthetic Biology Technology In Healthcare market revenue, 2020-2025, 2026-2031, ($ millions)
Global top five Synthetic Biology Technology In Healthcare companies in 2024 (%)
Total Market by Segment:
Global Synthetic Biology Technology In Healthcare market, by Type, 2020-2025, 2026-2031 ($ millions)
Global Synthetic Biology Technology In Healthcare market segment percentages, by Type, 2024 (%)
    Gene Editing Technology
    Metabolic Engineering
    Cell Factory Design
    Synthetic Genomics
    Others

Global Synthetic Biology Technology In Healthcare market, by Application, 2020-2025, 2026-2031 ($ millions)
Global Synthetic Biology Technology In Healthcare market segment percentages, by Application, 2024 (%)
    Drug Development
    Vaccine Design And Production
    Gene Therapy
    Cellular Immunotherapy
    Microecological Therapy

Global Synthetic Biology Technology In Healthcare market, by region and country, 2020-2025, 2026-2031 ($ millions)
Global Synthetic Biology Technology In Healthcare market segment percentages, by region and country, 2024 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Synthetic Biology Technology In Healthcare revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Synthetic Biology Technology In Healthcare revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Pfizer
    Merck
    Johnson & Johnson
    Anthem Biosciences
    Genomatica
    Illumina
    Synthetic Genomics
    Ginkgo Bioworks
    Novozymes
    Amyris
    Codexis
    Precigen
    Moderna Therapeutics
    BGI Genomics
    BeiGene
    Shandong Lukang Pharmaceutical
    Asymchem Laboratories
    Cathay Biotech
    HuaHao Tiancheng Biotechnology
    Vland Biotech Group
    Hybio Pharmaceutical
    Huadong Medicine
    WOTE Advanced Materials
    Hainan Poly Pharm
    Shandong Xinhua Pharmaceutical

Outline of Major Chapters:
Chapter 1: Introduces the definition of Synthetic Biology Technology In Healthcare, market overview.
Chapter 2: Global Synthetic Biology Technology In Healthcare market size in revenue.
Chapter 3: Detailed analysis of Synthetic Biology Technology In Healthcare company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Synthetic Biology Technology In Healthcare in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.